EMRC 21™ collects and handles various types of personal and sensitive information, including:

1. Personal identifiable information (PII) : Name, date of birth, address, phone number, email, and other contact details.
2. Sensitive information : Medical history, genetic data, health records, and other sensitive information related to research participants and patients.
3. Research data : Data collected during research studies, including surveys, interviews, and clinical trials.

EMRC 21™ collects personal and sensitive information for the following purposes:

1. Research : To conduct research studies, clinical trials, and other scientific investigations.
2. Healthcare : To provide medical care and treatment to patients.
3. Education : To educate students, researchers, and healthcare professionals.
4. Administration : To manage EMRC 21’s operations, including human resources, finance, and facilities management.

EMRC 21™ may disclose personal and sensitive information to:

1. Authorized personnel : EMRC 21™ employees, researchers, and affiliates who need access to the information to perform their duties.
2. Research collaborator : Researchers and institutions collaborating with EMRC 21™ on research projects.
3. Healthcare providers : Healthcare providers and institutions involved in the care and treatment of patients.
4. Regulatory authorities : Government agencies and regulatory bodies overseeing research, healthcare, and other activities.
5. Law enforcement : Law enforcement agencies, courts, and tribunals, as required by law.

EMRC 21™ implements various measures to protect personal and sensitive information, including:

1. Access controls : Limiting access to authorized personnel and using secure authentication mechanisms.
2. Encryption : Encrypting sensitive information, both in transit and at rest.
3. Firewalls : Using firewalls to protect against unauthorized access to EMRC 21’s systems and networks.
4. Secure storage : Storing personal and sensitive information in secure, access-controlled facilities.
5. Training and awareness : Providing training and awareness programs for EMRC 21™ employees and affiliates on privacy and data protection.

Research participants and patients have the right to:

1. Informed consent : Receive informed consent before participating in research studies or receiving medical care.
2. Access to information : Access their personal and sensitive information, subject to applicable laws and regulations.
3. Correction of information : Request corrections to their personal and sensitive information.
4. Withdrawal from research : Withdraw from research studies at any time, without penalty or loss of benefits.

In the event of a breach of personal and sensitive information, EMRC 21™ will:

1. Notify affected individuals : Notify research participants, patients, and other affected individuals of the breach, as required by law.
2. Conduct an investigation : Conduct an investigation into the breach and implement measures to prevent future breaches.
3. Notify regulatory authorities : Notify regulatory authorities, as required by law.

EMRC 21™ complies with applicable laws, regulations, and standards related to privacy and data protection, including:

1. Egyptian Data Protection Law : Law No. 151 of 2020.
2. General Data Protection Regulation (GDPR) : EU Regulation 2016/679.
3. Health Insurance Portability and Accountability Act (HIPAA) : US Public Law 104-191.

EMRC 21™ reserves the right to modify this policy at any time. Changes will be effective immediately upon posting on EMRC 21’s website.

If you have any questions or concerns about this policy or EMRC 21’s handling of personal and sensitive information, please contact:

Medicine 21™ – Egyptian Medical Research Center (EMRC 21™)
Head office : 40 El-Batrawy st., from Abbas El-Akkad st., Nasr City, Cairo, Egypt 
Reception mobile No. :  +2 – 010 – 630 012 870 
Email Address : info@medicine-21.com